Company · CIK 0001600620 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Aurinia Pharmaceuticals Inc. · AUPH
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 SForm 4 → | Sep 11, 4:26 pm EDT | Stephen P. RobertsonChief Legal Officer | 11,939 | $15.95 | $190,427 | 588,848 | −1.99% | |
| Aug 21, 2026 SForm 4 → | Aug 25, 9:29 pm EDT | Stephen P. RobertsonChief Legal Officer | 20,975 | $16.97 | $355,946 | 600,787 | −3.37% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 AForm 4 → | Jun 8, 4:14 pm EDT | Craig A JohnsonDirector | 23,931 | — | — | 23,931 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 4:12 pm EDT | Kathleen GoetzDirector | 23,931 | — | — | 23,931 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 4:10 pm EDT | Tina Susan NovaDirector | 23,931 | — | — | 23,931 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 4:08 pm EDT | Jeffrey Allen BaileyDirector | 23,931 | — | — | 23,931 | — |